Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BBIO
BBIO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BBIO News
BridgeBio Pharma Reports Strong Q1 2026 Earnings and $500M Buyback
2d ago
seekingalpha
BridgeBio Pharma Q1 Earnings Report Analysis
3d ago
seekingalpha
Brazil Approves Acoramidis for Cardiomyopathy Treatment
4d ago
Newsfilter
BridgeBio to Present ADH1 Study Data at European Congress of Endocrinology
5d ago
Newsfilter
BridgeBio to Present New Data at Heart Failure Conference
6d ago
Newsfilter
Pfizer Settles Patent Disputes with Generic Manufacturers
Apr 28 2026
stocktwits
BridgeBio Shares Surge 6.6% Following Pfizer Patent Settlement
Apr 28 2026
seekingalpha
New Campaign Enhances Awareness of ATTR-CM
Apr 28 2026
Newsfilter
BridgeBio Shares Rise on Patent Settlement Indications
Apr 24 2026
seekingalpha
BridgeBio Pharma Approves Employee Equity Grants
Apr 22 2026
Newsfilter
BridgeBio Pharma (BBIO.US) Director Plans to Sell $8.9 Million in Common Stock via Form 144
Apr 09 2026
moomoo
Healthcare Stocks Mixed as NYSE Health Care Index Edges Up 0.1%
Apr 09 2026
Yahoo Finance
Acoramidis Shows Significant Long-Term Benefits in Heart Failure Treatment
Mar 30 2026
Newsfilter
BridgeBio Submits NDA for BBP-418 to Treat LGMD2I/R9
Mar 30 2026
Newsfilter
BridgeBio Pharma (BBIO.US) Director Plans to Sell $9.52 Million in Common Stock via Form 144
Mar 13 2026
moomoo
BridgeBio Presents Positive Interim Data for BBP-418 in LGMD2I/R9
Mar 11 2026
Yahoo Finance
Show More News
